Japan’s CAR‑T Cell Therapy Market to Nearly Double by 2030

ELIQUENT Japan > Healthcare Investment

2025.07.22

Falling,pills,on,a,blue,background.,antibiotics.,3d,render.

Japan’s CAR‑T Cell Therapy Market to Nearly Double by 2030

Introduction to Market Forecast According to a news article (CAR-T細胞療法市場　30年に390億円、24年から２倍近く拡大　富士経済 | ニュース | ミ […]

COMPANY

Company Name: Eliquent Japan, Inc.
Location: Shinjuku i-Land Tower 41F, 6-5-1 Nishi Shinjuku, Shinjuku-ku 163-1341 Tokyo, Japan
Representative Director, CEO: Shunsuke Iwano
Business Scope: Regulatory Consulting
 Phone:+81-3-6304-5570